Prescription Drug Injuries – Page 2

Metro Nashville to Receive $23M From Historic National Opioid Settlement Benefiting Taxpayers by Funding Public Programs to Fight Ongoing Addiction Issues

City of Nashville Mayor John Cooper has announced that the city of Nashville will receive $23 million to recoup taxpayer funds allocated to emergency government responses to the opioid epidemic from 2017 through the present. The news comes in the wake of an historic $26 billion nationwide settlement with American opioid manufacturers and distributors reached

LieffCabraser2022-03-11T22:12:35+00:00March 11th, 2022|Prescription Drug Injuries, Public Good|

Thousands of U.S. communities to receive opioid recovery funds from $26 billion global settlements as soon as May 2022

Over 90% of litigating local governments have confirmed participation in the global settlements approved today by the “Big Three” drug distributors AmerisourceBergen, Cardinal Health, and McKesson, along with opioid manufacturer Johnson & Johnson Washington, D.C. (February 25, 2022) – Today, the National Prescription Opiate Litigation Plaintiffs’ Executive Committee confirmed participation of over 90% of litigating

LieffCabraser2022-02-25T18:04:51+00:00February 25th, 2022|Mass Tort, Prescription Drug Injuries, Public Good|

Native American Tribes Reach Proposed $590 Million Opioid Settlement With Johnson & Johnson and Distributors

As reported by The New York Times (subscription) and multiple other outlets, Native American tribes have reached a $590 million proposed settlement agreement with Johnson & Johnson and three of the country’s largest opioid distributors to resolve claims over the companies’ alleged role in fueling the massive opioid addiction crisis responsible

LieffCabraser2022-02-02T01:50:45+00:00February 2nd, 2022|Firm News, Prescription Drug Injuries|

Landmark Jury Verdict Holds Pharmacies Responsible for Their Role in the U.S. Opioid Crisis

As reported by Law360, in a first-of-its-kind ruling, a federal jury has found pharmacy giants CVS, Walgreens and Walmart liable for fueling the opioid addiction crisis in two Ohio counties. After a six-week trial and one week of deliberations, jurors concluded that the sale and distribution of huge amounts of prescription opioids by the pharmacy

LieffCabraser2021-11-24T19:17:25+00:00November 24th, 2021|Firm News, Prescription Drug Injuries|

National Prescription Opiate Litigation Plaintiffs’ Team Named Litigators of the Week by Am Law Litigation Daily

The Am Law Litigation Daily has named Lieff Cabraser partner Elizabeth Cabraser and her colleagues on the negotiating team of plaintiffs’ lawyers behind the recently revamped $26 billion proposed opioid settlement as its Litigators of the Week for their role in getting the deal with Johnson & Johnson and three opioid

LieffCabraser2022-08-10T17:09:27+00:00July 23rd, 2021|Awards, Firm News, Prescription Drug Injuries|

Ohio Judge Denies Pharmacies Attempt to Escape Public Nuisance In Opioid MDL

As reported by Law360 (subscription), an Ohio federal judge has denied attempts by Rite Aid, Walmart and other pharmacies to dismiss claims alleging their opioid monitoring systems were not reliable and that their failure to stop opioids from being obtained illegally created a public nuisance.

LieffCabraser2020-01-28T16:54:24+00:00January 28th, 2020|Prescription Drug Injuries|

Ohio Federal Judge Approves Opioid MDL ‘Negotiation Class’

As reported by Law360 (subscription), U.S. District Judge Dan Polster has approved the innovative and unprecedented approach of creating a negotiation class of government authorities empowered to negotiate a global settlement with drug manufacturers accused of fueling the destructive opioid addiction crisis that has swept the nation. The “negotiation class” concept was originally

LieffCabraser2019-09-12T15:54:40+00:00September 12th, 2019|Prescription Drug Injuries|

Ohio Federal Judge Indicating Support for “Negotiation Class” in Opioid MDL

As reported by Law360, U.S. District Judge Dan Polster appears to be signaling support for the inventive new settlement approach proposed earlier this summer by attorneys for local government plaintiffs in the federal opioids litigation on behalf of about 40 local government entities. According to the publication, in the nearly two-hour hearing held on August 6th,

LieffCabraser2019-08-06T11:25:41+00:00August 6th, 2019|Prescription Drug Injuries|

Plaintiffs Seek Relocation for Gilead Sciences Inferior HIV Drugs Trial

In lawsuits against pharma giant Gilead Sciences, plaintiffs across California allege they suffered ill effects from HIV drugs made and distributed by Gilead that were more harmful derivatives than other drugs the company had created but not sold until its stock of the inferior drugs was exhausted. As reported by the Daily Journal (subscription), attorneys

LieffCabraser2019-08-01T14:37:20+00:00August 1st, 2019|Personal Injury, Prescription Drug Injuries|

Ohio Federal Judge Open to Plaintiffs’ “Novel Ideal” for Faster Settlement of Nationwide Opioid MDL

As reported by Law360, U.S. District Judge Dan Polster appeared receptive to an inventive new settlement proposal introduced on behalf of about 40 local government entities by plaintiffs’ attorneys at the June 25 hearing in Ohio federal court. Judge Polster oversees nearly 2,000 lawsuits in the opioid multidistrict litigation. Plaintiffs’ proposal

LieffCabraser2022-08-10T17:30:12+00:00June 26th, 2019|Prescription Drug Injuries|